Sentiment-Signal
15,1
Stark Bearisch
Composite Score (0–100)
Insider (25%)
0
Keine Insider-Käufe
Institutionell (22,5%)
11
Keine neuen Positionen
Aktivist (12,5%)
0
Kein 13D/13G
Risikofreier Zins (T-Bills): 3,70% (Stand: 31.03.2026)
Score-Verlauf (90 Tage)
Kritische 8-K Meldungen
WARNUNG: Kritische 8-K-Meldung(en)
HOCH Abgang Schlüsselpersonen (19.02.2026)
HOCH Abgang Schlüsselpersonen (19.02.2026)
| Datum | Meldung | Schwere | Filing | Auszug |
|---|---|---|---|---|
| 19.02.2026 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | n such a filing. ITEM 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Off |
| 16.05.2025 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | ITEM 5.02 – Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensa |
| 17.04.2025 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | ITEM 5.02 – Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensa |
| 20.02.2025 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | e in such a filing. ITEM 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certai |
| 13.05.2024 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | ITEM 5.02 – Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensa |
| 11.05.2023 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | ITEM 5.02 – Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensa |
Stammdaten
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversible inhibitor of dipeptidyl peptidase 1 for the treatment of patients with bronchiectasis and other neutrophil-mediated diseases; and Treprostinil Palmitil Inhalation Powder, an inhaled formulation of a treprostinil prodrug treprostinil palmitil for the treatment of pulmonary arterial hypertension and other rare pulmonary disorders. Insmed Incorporated was founded in 1988 and is headquartered in Bridgewater, New Jersey.
Unternehmen & Branche
| Name | INSMED Inc |
|---|---|
| Ticker | INSM |
| CIK | 0001104506 |
| Boerse | US |
| Sektor | Healthcare |
| Industrie | Biotechnology |
| SIC | 2834 · Pharmaceutical Preparations |
Wertpapier & Kennzahlen
| CUSIP | 457669307 |
|---|---|
| ISIN | US4576693075 |
| Typ | Common Stock |
| Marktkapitalisierung | 30,93 Mrd. USD |
| Beta | 1,10 |
| Dividendenrendite | 0,00 % |
Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »
Finanzkennzahlen (SEC XBRL)
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2025-12-31 | 10-K | 606,423,000 | -1,276,775,000 | -6.42 | 2,264,558,000 | 738,976,000 |
| 2025-09-30 | 10-Q | 142,342,000 | -370,021,000 | -1.75 | 2,360,736,000 | 945,571,000 |
| 2025-06-30 | 10-Q | 107,415,000 | -321,686,000 | -1.70 | 2,479,857,000 | 1,249,735,000 |
| 2025-03-31 | 10-Q | 92,823,000 | -256,583,000 | -1.42 | 1,802,735,000 | 99,159,000 |
| 2024-12-31 | 10-K | 363,707,000 | -913,772,000 | -5.57 | 2,025,231,000 | 285,379,000 |
| 2024-09-30 | 10-Q | 93,425,000 | -220,524,000 | -1.27 | 2,052,972,000 | 483,415,000 |
| 2024-06-30 | 10-Q | 90,340,000 | -300,609,000 | -1.94 | 1,810,118,000 | 38,818,000 |
| 2024-03-31 | 10-Q | 75,500,000 | -157,091,000 | -1.06 | 1,159,095,000 | -464,808,000 |
| 2023-12-31 | 10-K | 305,208,000 | -749,567,000 | -5.34 | 1,329,837,000 | -331,923,000 |
| 2023-09-30 | 10-Q | 79,072,000 | -158,933,000 | -1.11 | 1,324,873,000 | -289,357,000 |
| 2023-06-30 | 10-Q | 77,229,000 | -244,809,000 | -1.78 | 1,439,139,000 | -155,745,000 |
| 2023-03-31 | 10-Q | 65,214,000 | -159,764,000 | -1.17 | 1,517,717,000 | -44,653,000 |
| 2022-12-31 | 10-K | 245,358,000 | -481,534,000 | -3.91 | 1,656,435,000 | 87,951,000 |
| 2022-09-30 | 10-Q | 67,730,000 | -131,145,000 | -1.09 | 994,817,000 | -29,959,000 |
| 2022-06-30 | 10-Q | 65,221,000 | -95,645,000 | -0.80 | 1,053,354,000 | 44,241,000 |
| 2022-03-31 | 10-Q | 53,107,000 | -94,621,000 | -0.80 | 1,153,315,000 | 119,880,000 |
| 2021-12-31 | 10-K | 188,461,000 | -434,654,000 | -3.88 | 1,243,508,000 | 410,468,000 |
| 2021-09-30 | 10-Q | 46,757,000 | -112,714,000 | -0.96 | 1,311,771,000 | 504,842,000 |
| 2021-06-30 | 10-Q | 45,366,000 | -117,321,000 | -1.07 | 1,229,783,000 | 531,053,000 |
| 2021-03-31 | 10-Q | 40,214,000 | -91,641,000 | -0.89 | 692,391,000 | 201,636,000 |
Fondsaktivität (Vorquartalsvergleich)
| Fonds | Aktuell (Stk) | Vorquartal (Stk) | Veränderung (Stk) | Wert (USD) | Status | Δ | Trend |
|---|---|---|---|---|---|---|---|
| JPMORGAN CHASE & CO | 23,556,212 | 0 | 23,556,212 | 4,099,723,379 | Neu | +100,0% | |
| VANGUARD GROUP INC | 21,076,344 | 0 | 21,076,344 | 3,668,126,910 | Neu | +100,0% | |
| BlackRock, Inc. | 15,065,052 | 0 | 15,065,052 | 2,621,921,693 | Neu | +100,0% | |
| FMR LLC | 9,927,936 | 0 | 9,927,936 | 1,727,857,942 | Neu | +100,0% | |
| BAKER BROS. ADVISORS LP | 6,592,746 | 0 | 6,592,746 | 1,147,401,514 | Neu | +100,0% | |
| STATE STREET CORP | 5,201,744 | 0 | 5,201,744 | 905,311,526 | Neu | +100,0% | |
| Capital International Investors | 5,151,671 | 0 | 5,151,671 | 896,597,082 | Neu | +100,0% | |
| RTW INVESTMENTS, LP | 4,842,879 | 0 | 4,842,879 | 842,854,661 | Neu | +100,0% | |
| D. E. Shaw & Co., Inc. | 4,364,695 | 0 | 4,364,695 | 759,631,518 | Neu | +100,0% | |
| GEODE CAPITAL MANAGEMENT, LLC | 4,299,052 | 0 | 4,299,052 | 751,935,864 | Neu | +100,0% | |
| Orbis Allan Gray Ltd | 4,179,957 | 0 | 4,179,957 | 727,479,716 | Neu | +100,0% | |
| NORGES BANK | 2,910,971 | 0 | 2,910,971 | 506,625,393 | Neu | +100,0% | |
| FRANKLIN RESOURCES INC | 2,755,536 | 0 | 2,755,536 | 479,573,482 | Neu | +100,0% | |
| Invesco Ltd. | 2,726,857 | 0 | 2,726,857 | 474,582,256 | Neu | +100,0% | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 2,392,776 | 0 | 2,392,776 | 416,438,735 | Neu | +100,0% | |
| AMERIPRISE FINANCIAL INC | 1,968,857 | 0 | 1,968,857 | 342,660,797 | Neu | +100,0% | |
| UBS Group AG | 1,950,835 | 0 | 1,950,835 | 339,523,322 | Neu | +100,0% | |
| CITADEL ADVISORS LLC | 1,808,995 | 0 | 1,808,995 | 314,837,490 | Neu | +100,0% | |
| BANK OF AMERICA CORP /DE/ | 1,725,681 | 0 | 1,725,681 | 300,337,528 | Neu | +100,0% | |
| MORGAN STANLEY | 1,631,906 | 0 | 1,631,906 | 284,017,467 | Neu | +100,0% | |
| MILLENNIUM MANAGEMENT LLC | 1,312,854 | 0 | 1,312,854 | 228,489,110 | Neu | +100,0% | |
| GOLDMAN SACHS GROUP INC | 1,303,413 | 0 | 1,303,413 | 226,846,072 | Neu | +100,0% | |
| NORTHERN TRUST CORP | 1,238,438 | 0 | 1,238,438 | 215,537,748 | Neu | +100,0% | |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 1,221,096 | 0 | 1,221,096 | 212,519,548 | Neu | +100,0% | |
| JANE STREET GROUP, LLC | 1,034,205 | 0 | 1,034,205 | 179,993,038 | Neu | +100,0% | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1,027,355 | 0 | 1,027,355 | 178,800,864 | Neu | +100,0% | |
| Jefferies Financial Group Inc. | 1,026,239 | 0 | 1,026,239 | 178,606,636 | Neu | +100,0% | |
| Fiera Capital Corp | 992,892 | 0 | 992,892 | 172,802,924 | Neu | +100,0% | |
| TWO SIGMA INVESTMENTS, LP | 962,156 | 0 | 962,156 | 167,453,630 | Neu | +100,0% | |
| Pictet Asset Management Holding SA | 958,963 | 0 | 958,963 | 167,256,939 | Neu | +100,0% | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 943,306 | 0 | 943,306 | 164,172,977 | Neu | +100,0% | |
| BNP PARIBAS FINANCIAL MARKETS | 915,419 | 0 | 915,419 | 159,319,523 | Neu | +100,0% | |
| SEI INVESTMENTS CO | 890,170 | 0 | 890,170 | 154,924,615 | Neu | +100,0% | |
| FIL Ltd | 838,509 | 0 | 838,509 | 145,934,106 | Neu | +100,0% | |
| Clearbridge Investments, LLC | 819,011 | 0 | 819,011 | 142,540,702 | Neu | +100,0% | |
| JANUS HENDERSON GROUP PLC | 800,555 | 0 | 800,555 | 139,334,263 | Neu | +100,0% | |
| RAYMOND JAMES FINANCIAL INC | 779,254 | 0 | 779,254 | 135,649,715 | Neu | +100,0% | |
| PRINCIPAL FINANCIAL GROUP INC | 771,358 | 0 | 771,358 | 134,247,146 | Neu | +100,0% | |
| VICTORY CAPITAL MANAGEMENT INC | 646,714 | 0 | 646,714 | 112,554,105 | Neu | +100,0% | |
| ALLIANCEBERNSTEIN L.P. | 642,719 | 0 | 642,719 | 111,858,815 | Neu | +100,0% | |
| Caption Management, LLC | 599,400 | 0 | 599,400 | 104,319,576 | Neu | +100,0% | |
| DEUTSCHE BANK AG\ | 590,030 | 0 | 590,030 | 102,688,822 | Neu | +100,0% | |
| WELLS FARGO & COMPANY/MN | 586,651 | 0 | 586,651 | 102,100,688 | Neu | +100,0% | |
| Swiss National Bank | 579,112 | 0 | 579,112 | 100,788,652 | Neu | +100,0% | |
| SUSQUEHANNA ADVISORS GROUP, INC. | 565,000 | 0 | 565,000 | 98,332,600 | Neu | +100,0% | |
| JENNISON ASSOCIATES LLC | 562,296 | 0 | 562,296 | 97,862,072 | Neu | +100,0% | |
| Legal & General Group Plc | 540,313 | 0 | 540,313 | 94,036,075 | Neu | +100,0% | |
| ROYAL BANK OF CANADA | 506,811 | 0 | 506,811 | 88,205,000 | Neu | +100,0% | |
| Nearwater Capital Markets, Ltd | 500,000 | 0 | 500,000 | 87,020,000 | Neu | +100,0% | |
| Palo Alto Investors LP | 489,482 | 0 | 489,482 | 85,189,447 | Neu | +100,0% |
Insider-Transaktionen (12 Monate)
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2026-04-16 | Lewis William | Director, Officer, Chair and CEO | Open Market Sale | -5,373 | 143.81 | -772,691.13 | -80,2% | |
| 2026-04-16 | Lewis William | Director, Officer, Chair and CEO | Open Market Sale | -2,246 | 142.99 | -321,155.54 | -33,3% | |
| 2026-04-16 | Lewis William | Director, Officer, Chair and CEO | Open Market Sale | -2,255 | 144.66 | -326,208.30 | -33,8% | |
| 2026-04-16 | Lewis William | Director, Officer, Chair and CEO | Open Market Sale | -825 | 145.79 | -120,276.75 | -12,5% | |
| 2026-04-06 | Lewis William | Director, Officer, Chair and CEO | Open Market Sale | -1,434 | 164.01 | -235,190.34 | -24,4% | |
| 2026-04-06 | Lewis William | Director, Officer, Chair and CEO | Open Market Sale | -8,478 | 163.23 | -1,383,863.94 | -143,6% | |
| 2026-04-06 | Lewis William | Director, Officer, Chair and CEO | Open Market Sale | -787 | 161.73 | -127,281.51 | -13,2% | |
| 2026-04-01 | Adsett Roger | Officer, Chief Operating Officer | Open Market Sale | -6,715 | 163.18 | -1,095,753.70 | -113,7% | |
| 2026-04-01 | Adsett Roger | Officer, Chief Operating Officer | Open Market Sale | -62,344 | 164.95 | -10,283,642.80 | -1067,0% | |
| 2026-04-01 | Adsett Roger | Officer, Chief Operating Officer | Open Market Sale | -19,001 | 164.11 | -3,118,254.11 | -323,5% | |
| 2026-03-30 | Smith Michael Alexander | Officer, Chief Legal Officer | Open Market Sale | -19,638 | 150.98 | -2,964,945.24 | -307,6% | |
| 2026-03-19 | Lewis William | Director, Officer, Chair and CEO | Open Market Sale | -4,533 | 144.11 | -653,250.63 | -67,8% | |
| 2026-03-19 | Lewis William | Director, Officer, Chair and CEO | Open Market Sale | -4,537 | 143.42 | -650,696.54 | -67,5% | |
| 2026-03-19 | Lewis William | Director, Officer, Chair and CEO | Open Market Sale | -1,629 | 142.17 | -231,594.93 | -24,0% | |
| 2026-03-05 | Lewis William | Director, Officer, Chair and CEO | Open Market Sale | -2,128 | 147.54 | -313,965.12 | -32,6% | |
| 2026-03-05 | Lewis William | Director, Officer, Chair and CEO | Open Market Sale | -3,899 | 146.66 | -571,827.34 | -59,3% | |
| 2026-03-05 | Lewis William | Director, Officer, Chair and CEO | Open Market Sale | -2,589 | 145.27 | -376,104.03 | -39,0% | |
| 2026-03-05 | Lewis William | Director, Officer, Chair and CEO | Open Market Sale | -2,083 | 144.23 | -300,431.09 | -31,2% | |
| 2026-02-24 | Smith Michael Alexander | Officer, Chief Legal Officer | Open Market Sale | -4,852 | 153.93 | -746,868.36 | -77,5% | |
| 2026-02-24 | Smith Michael Alexander | Officer, Chief Legal Officer | Open Market Sale | -15,771 | 156.53 | -2,468,634.63 | -256,1% | |
| 2026-02-24 | Smith Michael Alexander | Officer, Chief Legal Officer | Open Market Sale | -4,151 | 155.06 | -643,654.06 | -66,8% | |
| 2026-02-19 | Lewis William | Director, Officer, Chair and CEO | Open Market Sale | -3,413 | 151.12 | -515,772.56 | -53,5% | |
| 2026-02-19 | Lewis William | Director, Officer, Chair and CEO | Open Market Sale | -2,377 | 151.92 | -361,113.84 | -37,5% | |
| 2026-02-19 | Lewis William | Director, Officer, Chair and CEO | Open Market Sale | -1,988 | 149.17 | -296,549.96 | -30,8% | |
| 2026-02-19 | Lewis William | Director, Officer, Chair and CEO | Open Market Sale | -1,891 | 150.10 | -283,839.10 | -29,5% | |
| 2026-02-19 | Lewis William | Director, Officer, Chair and CEO | Open Market Sale | -1,030 | 153.38 | -157,981.40 | -16,4% | |
| 2026-02-09 | Lewis William | Director, Officer, Chair and CEO | Open Market Sale | -7,221 | 148.02 | -1,068,852.42 | -110,9% | |
| 2026-02-09 | Lewis William | Director, Officer, Chair and CEO | Open Market Sale | -4,888 | 147.17 | -719,366.96 | -74,6% | |
| 2026-02-09 | Lewis William | Director, Officer, Chair and CEO | Open Market Sale | -1,287 | 148.83 | -191,544.21 | -19,9% | |
| 2026-02-05 | Flammer Martina M.D. | Officer, Chief Medical Officer | Open Market Sale | -869 | 152.44 | -132,470.36 | -13,7% | |
| 2026-02-03 | Flammer Martina M.D. | Officer, Chief Medical Officer | Open Market Sale | -795 | 155.77 | -123,837.15 | -12,8% | |
| 2026-02-03 | Bonstein Sara | Officer, Chief Financial Officer | Open Market Sale | -748 | 156.34 | -116,942.32 | -12,1% | |
| 2026-02-03 | Adsett Roger | Officer, Chief Operating Officer | Open Market Sale | -791 | 156.17 | -123,530.47 | -12,8% | |
| 2026-02-03 | Lewis William | Director, Officer, Chair and CEO | Open Market Sale | -3,009 | 156.34 | -470,427.06 | -48,8% | |
| 2026-02-03 | Smith Michael Alexander | Officer, Chief Legal Officer | Open Market Sale | -640 | 156.27 | -100,012.80 | -10,4% | |
| 2026-02-02 | Flammer Martina M.D. | Officer, Chief Medical Officer | Open Market Sale | -3,349 | 154.56 | -517,621.44 | -53,7% | |
| 2026-02-02 | Flammer Martina M.D. | Officer, Chief Medical Officer | Open Market Sale | -3,042 | 155.46 | -472,909.32 | -49,1% | |
| 2026-02-02 | Flammer Martina M.D. | Officer, Chief Medical Officer | Open Market Sale | -928 | 153.16 | -142,132.48 | -14,7% | |
| 2026-02-02 | Flammer Martina M.D. | Officer, Chief Medical Officer | Open Market Sale | -563 | 152.06 | -85,609.78 | -8,9% | |
| 2026-02-02 | Flammer Martina M.D. | Officer, Chief Medical Officer | Open Market Sale | -100 | 156.86 | -15,686.00 | -1,6% | |
| 2026-01-20 | Lewis William | Director, Officer, Chair and CEO | Open Market Sale | -1,243 | 158.37 | -196,853.91 | -20,4% | |
| 2026-01-20 | Lewis William | Director, Officer, Chair and CEO | Open Market Sale | -254 | 160.70 | -40,817.80 | -4,2% | |
| 2026-01-20 | Lewis William | Director, Officer, Chair and CEO | Open Market Sale | -5,967 | 158.99 | -948,693.33 | -98,4% | |
| 2026-01-20 | Lewis William | Director, Officer, Chair and CEO | Open Market Sale | -2,229 | 159.85 | -356,305.65 | -37,0% | |
| 2026-01-20 | Lewis William | Director, Officer, Chair and CEO | Open Market Sale | -1,006 | 156.80 | -157,740.80 | -16,4% | |
| 2026-01-12 | Lewis William | Director, Officer, Chair and CEO | Open Market Sale | -297 | 171.31 | -50,879.07 | -5,3% | |
| 2026-01-12 | Lewis William | Director, Officer, Chair and CEO | Open Market Sale | -7,176 | 168.63 | -1,210,088.88 | -125,6% | |
| 2026-01-12 | Lewis William | Director, Officer, Chair and CEO | Open Market Sale | -6,996 | 169.57 | -1,186,311.72 | -123,1% | |
| 2026-01-12 | Lewis William | Director, Officer, Chair and CEO | Open Market Sale | -3,974 | 167.73 | -666,559.02 | -69,2% | |
| 2026-01-12 | Lewis William | Director, Officer, Chair and CEO | Open Market Sale | -315 | 174.86 | -55,080.90 | -5,7% | |
| 2026-01-12 | Lewis William | Director, Officer, Chair and CEO | Open Market Sale | -297 | 172.36 | -51,190.92 | -5,3% | |
| 2026-01-12 | Lewis William | Director, Officer, Chair and CEO | Open Market Sale | -160 | 170.24 | -27,238.40 | -2,8% | |
| 2026-01-09 | Flammer Martina M.D. | Officer, Chief Medical Officer | Open Market Sale | -1,887 | 186.19 | -351,340.53 | -36,5% | |
| 2026-01-08 | Flammer Martina M.D. | Officer, Chief Medical Officer | Open Market Sale | -3,251 | 174.17 | -566,226.67 | -58,8% | |
| 2026-01-08 | Flammer Martina M.D. | Officer, Chief Medical Officer | Open Market Sale | -1,660 | 173.87 | -288,624.20 | -29,9% | |
| 2026-01-08 | Bonstein Sara | Officer, Chief Financial Officer | Open Market Sale | -1,447 | 174.17 | -252,023.99 | -26,1% | |
| 2026-01-08 | Smith Michael Alexander | Officer, Chief Legal Officer | Open Market Sale | -1,053 | 174.17 | -183,401.01 | -19,0% | |
| 2026-01-08 | Adsett Roger | Officer, Chief Operating Officer | Open Market Sale | -2,059 | 174.17 | -358,616.03 | -37,2% | |
| 2026-01-08 | Lewis William | Director, Officer, Chair and CEO | Open Market Sale | -3,223 | 174.17 | -561,349.91 | -58,2% | |
| 2026-01-07 | Smith Michael Alexander | Officer, Chief Legal Officer | Open Market Sale | -709 | 175.07 | -124,124.63 | -12,9% | |
| 2026-01-07 | Lewis William | Director, Officer, Chair and CEO | Open Market Sale | -2,357 | 175.07 | -412,639.99 | -42,8% | |
| 2026-01-07 | Adsett Roger | Officer, Chief Operating Officer | Open Market Sale | -802 | 175.07 | -140,406.14 | -14,6% | |
| 2026-01-07 | Flammer Martina M.D. | Officer, Chief Medical Officer | Open Market Sale | -1,434 | 175.84 | -252,154.56 | -26,2% | |
| 2026-01-07 | Bonstein Sara | Officer, Chief Financial Officer | Open Market Sale | -1,678 | 175.07 | -293,767.46 | -30,5% | |
| 2026-01-06 | Flammer Martina M.D. | Officer, Chief Medical Officer | Open Market Sale | -2,830 | 174.21 | -493,014.30 | -51,2% | |
| 2026-01-06 | Flammer Martina M.D. | Officer, Chief Medical Officer | Open Market Sale | -1,615 | 173.33 | -279,927.95 | -29,0% | |
| 2026-01-06 | Flammer Martina M.D. | Officer, Chief Medical Officer | Open Market Sale | -957 | 175.01 | -167,484.57 | -17,4% | |
| 2026-01-06 | Adsett Roger | Officer, Chief Operating Officer | Open Market Sale | -1,429 | 173.33 | -247,688.57 | -25,7% | |
| 2026-01-06 | Smith Michael Alexander | Officer, Chief Legal Officer | Open Market Sale | -1,396 | 173.33 | -241,968.68 | -25,1% | |
| 2026-01-06 | Bonstein Sara | Officer, Chief Financial Officer | Open Market Sale | -1,517 | 173.33 | -262,941.61 | -27,3% | |
| 2026-01-06 | Lewis William | Director, Officer, Chair and CEO | Open Market Sale | -4,096 | 173.33 | -709,959.68 | -73,7% | |
| 2026-01-06 | Flammer Martina M.D. | Officer, Chief Medical Officer | Open Market Sale | -4,783 | 173.47 | -829,707.01 | -86,1% | |
| 2026-01-05 | Flammer Martina M.D. | Officer, Chief Medical Officer | Open Market Sale | -655 | 174.28 | -114,153.40 | -11,8% | |
| 2026-01-05 | Flammer Martina M.D. | Officer, Chief Medical Officer | Open Market Sale | -3,205 | 170.61 | -546,805.05 | -56,7% | |
| 2026-01-05 | Flammer Martina M.D. | Officer, Chief Medical Officer | Open Market Sale | -2,836 | 171.19 | -485,494.84 | -50,4% | |
| 2026-01-05 | Flammer Martina M.D. | Officer, Chief Medical Officer | Open Market Sale | -2,799 | 169.29 | -473,842.71 | -49,2% | |
| 2026-01-05 | Flammer Martina M.D. | Officer, Chief Medical Officer | Open Market Sale | -1,820 | 173.45 | -315,679.00 | -32,8% | |
| 2026-01-05 | Flammer Martina M.D. | Officer, Chief Medical Officer | Open Market Sale | -702 | 175.73 | -123,362.46 | -12,8% | |
| 2026-01-05 | Flammer Martina M.D. | Officer, Chief Medical Officer | Open Market Sale | -286 | 171.92 | -49,169.12 | -5,1% | |
| 2026-01-02 | Schaeffer Orlov S Nicole | Officer, Chief People Strategy Officer | Open Market Sale | -31,030 | 174.28 | -5,407,908.40 | -561,1% | |
| 2026-01-02 | Schaeffer Orlov S Nicole | Officer, Chief People Strategy Officer | Open Market Sale | -200 | 177.78 | -35,556.00 | -3,7% | |
| 2026-01-02 | Schaeffer Orlov S Nicole | Officer, Chief People Strategy Officer | Open Market Sale | -34,103 | 175.17 | -5,973,822.51 | -619,8% | |
| 2026-01-02 | Schaeffer Orlov S Nicole | Officer, Chief People Strategy Officer | Open Market Sale | -9,125 | 177.17 | -1,616,676.25 | -167,7% | |
| 2026-01-02 | Schaeffer Orlov S Nicole | Officer, Chief People Strategy Officer | Open Market Sale | -12,832 | 176.08 | -2,259,458.56 | -234,4% | |
| 2025-12-18 | Lewis William | Director, Officer, Chair and CEO | Open Market Sale | -1,431 | 167.29 | -239,391.99 | -24,8% | |
| 2025-12-18 | Lewis William | Director, Officer, Chair and CEO | Open Market Sale | -697 | 165.21 | -115,151.37 | -11,9% | |
| 2025-12-18 | Lewis William | Director, Officer, Chair and CEO | Open Market Sale | -447 | 164.24 | -73,415.28 | -7,6% | |
| 2025-12-18 | Lewis William | Director, Officer, Chair and CEO | Open Market Sale | -362 | 170.26 | -61,634.12 | -6,4% | |
| 2025-12-18 | Lewis William | Director, Officer, Chair and CEO | Open Market Sale | -350 | 162.26 | -56,791.00 | -5,9% | |
| 2025-12-18 | Lewis William | Director, Officer, Chair and CEO | Open Market Sale | -51 | 171.20 | -8,731.20 | -0,9% | |
| 2025-12-18 | Lewis William | Director, Officer, Chair and CEO | Open Market Sale | -2,175 | 168.54 | -366,574.50 | -38,0% | |
| 2025-12-18 | Lewis William | Director, Officer, Chair and CEO | Open Market Sale | -1,938 | 169.58 | -328,646.04 | -34,1% | |
| 2025-12-18 | Lewis William | Director, Officer, Chair and CEO | Open Market Sale | -1,783 | 166.60 | -297,047.80 | -30,8% | |
| 2025-12-18 | Lewis William | Director, Officer, Chair and CEO | Open Market Sale | -1,465 | 163.19 | -239,073.35 | -24,8% | |
| 2025-12-05 | SHAROKY MELVIN MD | Director | Open Market Sale | -20,000 | 205.01 | -4,100,200.00 | -425,4% | |
| 2025-12-04 | Lewis William | Director, Officer, Chair and CEO | Open Market Sale | -2,921 | 206.49 | -603,157.29 | -62,6% | |
| 2025-12-04 | Lewis William | Director, Officer, Chair and CEO | Open Market Sale | -1,040 | 207.42 | -215,716.80 | -22,4% | |
| 2025-12-04 | Lewis William | Director, Officer, Chair and CEO | Open Market Sale | -4,516 | 204.62 | -924,063.92 | -95,9% | |
| 2025-12-04 | Lewis William | Director, Officer, Chair and CEO | Open Market Sale | -2,222 | 205.66 | -456,976.52 | -47,4% | |
| 2025-12-01 | Flammer Martina M.D. | Officer, Chief Medical Officer | Open Market Sale | -5,886 | 207.03 | -1,218,578.58 | -126,4% | |
| 2025-12-01 | Flammer Martina M.D. | Officer, Chief Medical Officer | Open Market Sale | -1,559 | 207.73 | -323,851.07 | -33,6% | |
| 2025-12-01 | Flammer Martina M.D. | Officer, Chief Medical Officer | Open Market Sale | -1,450 | 205.98 | -298,671.00 | -31,0% | |
| 2025-11-24 | ANDERSON ELIZABETH M | Director | Open Market Sale | -5,000 | 204.58 | -1,022,900.00 | -106,1% | |
| 2025-11-17 | LEE LEO | Director | Open Market Sale | -24,076 | 196.61 | -4,733,582.36 | -491,1% | |
| 2025-11-17 | LEE LEO | Director | Open Market Sale | -3,212 | 193.51 | -621,554.12 | -64,5% | |
| 2025-11-17 | LEE LEO | Director | Open Market Sale | -14,944 | 195.39 | -2,919,908.16 | -303,0% | |
| 2025-11-17 | LEE LEO | Director | Open Market Sale | -15,174 | 197.40 | -2,995,347.60 | -310,8% | |
| 2025-11-17 | LEE LEO | Director | Open Market Sale | -17,594 | 194.49 | -3,421,857.06 | -355,0% | |
| 2025-11-14 | ANDERSON ELIZABETH M | Director | Open Market Sale | -10,000 | 195.87 | -1,958,700.00 | -203,2% | |
| 2025-11-11 | Flammer Martina M.D. | Officer, Chief Medical Officer | Open Market Sale | -10,622 | 190.33 | -2,021,685.26 | -209,8% | |
| 2025-11-11 | Flammer Martina M.D. | Officer, Chief Medical Officer | Open Market Sale | -5,467 | 188.38 | -1,029,873.46 | -106,9% | |
| 2025-11-11 | Flammer Martina M.D. | Officer, Chief Medical Officer | Open Market Sale | -2,913 | 191.04 | -556,499.52 | -57,7% | |
| 2025-11-11 | Flammer Martina M.D. | Officer, Chief Medical Officer | Open Market Sale | -12,224 | 189.36 | -2,314,736.64 | -240,2% | |
| 2025-11-03 | Smith Michael Alexander | Officer, Chief Legal Officer | Open Market Sale | -3,243 | 184.91 | -599,663.13 | -62,2% | |
| 2025-11-03 | Smith Michael Alexander | Officer, Chief Legal Officer | Open Market Sale | -1,572 | 187.15 | -294,199.80 | -30,5% | |
| 2025-11-03 | Smith Michael Alexander | Officer, Chief Legal Officer | Open Market Sale | -1,342 | 181.01 | -242,915.42 | -25,2% | |
| 2025-11-03 | Smith Michael Alexander | Officer, Chief Legal Officer | Open Market Sale | -1,400 | 187.97 | -263,158.00 | -27,3% | |
| 2025-11-03 | Smith Michael Alexander | Officer, Chief Legal Officer | Open Market Sale | -7,619 | 181.88 | -1,385,743.72 | -143,8% | |
| 2025-11-03 | Smith Michael Alexander | Officer, Chief Legal Officer | Open Market Sale | -4,286 | 182.60 | -782,623.60 | -81,2% | |
| 2025-11-03 | Smith Michael Alexander | Officer, Chief Legal Officer | Open Market Sale | -4,032 | 183.92 | -741,565.44 | -76,9% | |
| 2025-11-03 | Smith Michael Alexander | Officer, Chief Legal Officer | Open Market Sale | -3,636 | 185.93 | -676,041.48 | -70,1% | |
| 2025-09-12 | Schaeffer Orlov S Nicole | Officer, Chief People Strategy Officer | Open Market Sale | -7,304 | 146.57 | -1,070,547.28 | -111,1% | |
| 2025-09-12 | SHAROKY MELVIN MD | Director | Open Market Sale | -10,000 | 145.39 | -1,453,900.00 | -150,9% | |
| 2025-09-12 | Schaeffer Orlov S Nicole | Officer, Chief People Strategy Officer | Open Market Sale | -32,091 | 144.60 | -4,640,358.60 | -481,5% | |
| 2025-09-12 | Schaeffer Orlov S Nicole | Officer, Chief People Strategy Officer | Open Market Sale | -30,967 | 145.67 | -4,510,962.89 | -468,0% | |
| 2025-09-12 | Schaeffer Orlov S Nicole | Officer, Chief People Strategy Officer | Open Market Sale | -6,158 | 147.46 | -908,058.68 | -94,2% | |
| 2025-09-02 | Flammer Martina M.D. | Officer, Chief Medical Officer | Open Market Sale | -28,063 | 144.05 | -4,042,475.15 | -419,4% | |
| 2025-09-02 | Smith Michael Alexander | Officer, Chief Legal Officer | Open Market Sale | -8,300 | 144.16 | -1,196,528.00 | -124,1% | |
| 2025-09-02 | Smith Michael Alexander | Officer, Chief Legal Officer | Open Market Sale | -7,391 | 143.16 | -1,058,095.56 | -109,8% | |
| 2025-09-02 | Smith Michael Alexander | Officer, Chief Legal Officer | Open Market Sale | -4,944 | 145.18 | -717,769.92 | -74,5% | |
| 2025-09-02 | Smith Michael Alexander | Officer, Chief Legal Officer | Open Market Sale | -1,354 | 141.16 | -191,130.64 | -19,8% | |
| 2025-09-02 | Smith Michael Alexander | Officer, Chief Legal Officer | Open Market Sale | -1,183 | 145.89 | -172,587.87 | -17,9% | |
| 2025-09-02 | Smith Michael Alexander | Officer, Chief Legal Officer | Open Market Sale | -1,100 | 142.06 | -156,266.00 | -16,2% | |
| 2025-09-02 | Flammer Martina M.D. | Officer, Chief Medical Officer | Open Market Sale | -63,782 | 145.33 | -9,269,438.06 | -961,8% | |
| 2025-09-02 | Flammer Martina M.D. | Officer, Chief Medical Officer | Open Market Sale | -35,245 | 143.16 | -5,045,674.20 | -523,5% | |
| 2025-09-02 | Flammer Martina M.D. | Officer, Chief Medical Officer | Open Market Sale | -34,615 | 146.05 | -5,055,520.75 | -524,5% | |
| 2025-09-02 | Flammer Martina M.D. | Officer, Chief Medical Officer | Open Market Sale | -19,066 | 141.27 | -2,693,453.82 | -279,5% | |
| 2025-09-02 | Flammer Martina M.D. | Officer, Chief Medical Officer | Open Market Sale | -5,877 | 142.03 | -834,710.31 | -86,6% | |
| 2025-08-20 | SHAROKY MELVIN MD | Director | Open Market Sale | -10,000 | 129.50 | -1,295,000.00 | -134,4% | |
| 2025-08-19 | Adsett Roger | Officer, Chief Operating Officer | Open Market Sale | -20,193 | 127.42 | -2,572,992.06 | -267,0% | |
| 2025-08-19 | Adsett Roger | Officer, Chief Operating Officer | Open Market Sale | -4,807 | 128.27 | -616,593.89 | -64,0% | |
| 2025-08-18 | Lewis William | Director, Officer, Chair and CEO | Open Market Sale | -1,416 | 129.47 | -183,329.52 | -19,0% | |
| 2025-08-18 | Lewis William | Director, Officer, Chair and CEO | Open Market Sale | -2,968 | 127.59 | -378,687.12 | -39,3% | |
| 2025-08-18 | Lewis William | Director, Officer, Chair and CEO | Open Market Sale | -2,481 | 128.76 | -319,453.56 | -33,1% | |
| 2025-08-14 | Schaeffer Orlov S Nicole | Officer, Chief People Strategy Officer | Open Market Sale | -700 | 128.16 | -89,712.00 | -9,3% | |
| 2025-08-14 | Schaeffer Orlov S Nicole | Officer, Chief People Strategy Officer | Open Market Sale | -5,746 | 127.71 | -733,821.66 | -76,1% | |
| 2025-08-14 | Schaeffer Orlov S Nicole | Officer, Chief People Strategy Officer | Open Market Sale | -3,554 | 126.57 | -449,829.78 | -46,7% | |
| 2025-08-12 | SHAROKY MELVIN MD | Director | Open Market Sale | -10,000 | 121.58 | -1,215,800.00 | -126,1% | |
| 2025-08-04 | Flammer Martina M.D. | Officer, Chief Medical Officer | Open Market Sale | -8,715 | 109.50 | -954,292.50 | -99,0% | |
| 2025-08-04 | Lewis William | Director, Officer, Chair and CEO | Open Market Sale | -3,199 | 109.68 | -350,866.32 | -36,4% | |
| 2025-08-04 | Lewis William | Director, Officer, Chair and CEO | Open Market Sale | -1,938 | 110.91 | -214,943.58 | -22,3% | |
| 2025-08-04 | Lewis William | Director, Officer, Chair and CEO | Open Market Sale | -1,693 | 108.80 | -184,198.40 | -19,1% | |
| 2025-07-21 | Bonstein Sara | Officer, Chief Financial Officer | Open Market Sale | -26,310 | 103.03 | -2,710,719.30 | -281,3% | |
| 2025-07-21 | Bonstein Sara | Officer, Chief Financial Officer | Open Market Sale | -32,090 | 102.38 | -3,285,374.20 | -340,9% | |
| 2025-07-15 | Smith Michael Alexander | Officer, Chief Legal Officer | Open Market Sale | -933 | 102.51 | -95,641.83 | -9,9% | |
| 2025-07-15 | Lewis William | Director, Officer, Chair and CEO | Open Market Sale | -4,492 | 102.66 | -461,148.72 | -47,8% | |
| 2025-07-15 | Lewis William | Director, Officer, Chair and CEO | Open Market Sale | -2,168 | 101.71 | -220,507.28 | -22,9% | |
| 2025-07-15 | Lewis William | Director, Officer, Chair and CEO | Open Market Sale | -170 | 103.32 | -17,564.40 | -1,8% | |
| 2025-07-11 | Smith Michael Alexander | Officer, Chief Legal Officer | Open Market Sale | -748 | 96.41 | -72,114.68 | -7,5% | |
| 2025-07-07 | Bonstein Sara | Officer, Chief Financial Officer | Open Market Sale | -22,181 | 96.19 | -2,133,590.39 | -221,4% | |
| 2025-07-07 | Bonstein Sara | Officer, Chief Financial Officer | Open Market Sale | -35,583 | 95.66 | -3,403,869.78 | -353,2% | |
| 2025-07-01 | Lewis William | Director, Officer, Chair and CEO | Open Market Sale | -2,349 | 98.83 | -232,151.67 | -24,1% | |
| 2025-07-01 | Lewis William | Director, Officer, Chair and CEO | Open Market Sale | -815 | 99.61 | -81,182.15 | -8,4% | |
| 2025-07-01 | Lewis William | Director, Officer, Chair and CEO | Open Market Sale | -3,666 | 97.73 | -358,278.18 | -37,2% | |
| 2025-06-23 | Bonstein Sara | Officer, Chief Financial Officer | Open Market Sale | -49,104 | 101.71 | -4,994,367.84 | -518,2% | |
| 2025-06-23 | Bonstein Sara | Officer, Chief Financial Officer | Open Market Sale | -8,661 | 102.15 | -884,721.15 | -91,8% | |
| 2025-06-16 | Lewis William | Director, Officer, Chair and CEO | Open Market Sale | -1,558 | 99.65 | -155,254.70 | -16,1% | |
| 2025-06-16 | Lewis William | Director, Officer, Chair and CEO | Open Market Sale | -442 | 98.51 | -43,541.42 | -4,5% | |
| 2025-06-16 | Lewis William | Director, Officer, Chair and CEO | Open Market Sale | -904 | 101.39 | -91,656.56 | -9,5% | |
| 2025-06-16 | Adsett Roger | Officer, Chief Operating Officer | Open Market Sale | -6,500 | 98.50 | -640,250.00 | -66,4% | |
| 2025-06-16 | Adsett Roger | Officer, Chief Operating Officer | Open Market Sale | -4,186 | 99.32 | -415,753.52 | -43,1% | |
| 2025-06-16 | Lewis William | Director, Officer, Chair and CEO | Open Market Sale | -48,531 | 100.54 | -4,879,306.74 | -506,3% | |
| 2025-06-16 | Lewis William | Director, Officer, Chair and CEO | Open Market Sale | -41,784 | 101.23 | -4,229,794.32 | -438,9% | |
| 2025-06-16 | Lewis William | Director, Officer, Chair and CEO | Open Market Sale | -32,490 | 99.51 | -3,233,079.90 | -335,5% | |
| 2025-06-16 | Lewis William | Director, Officer, Chair and CEO | Open Market Sale | -7,000 | 98.50 | -689,500.00 | -71,5% | |
| 2025-06-16 | Lewis William | Director, Officer, Chair and CEO | Open Market Sale | -2,300 | 100.70 | -231,610.00 | -24,0% | |
| 2025-06-10 | Bonstein Sara | Officer, Chief Financial Officer | Open Market Sale | -6,328 | 90.93 | -575,405.04 | -59,7% | |
| 2025-06-10 | Bonstein Sara | Officer, Chief Financial Officer | Open Market Sale | -20,926 | 88.99 | -1,862,204.74 | -193,2% | |
| 2025-06-10 | Bonstein Sara | Officer, Chief Financial Officer | Open Market Sale | -15,825 | 89.85 | -1,421,876.25 | -147,5% | |
| 2025-06-10 | Bonstein Sara | Officer, Chief Financial Officer | Open Market Sale | -7,310 | 88.29 | -645,399.90 | -67,0% | |
| 2025-06-10 | Bonstein Sara | Officer, Chief Financial Officer | Open Market Sale | -7,277 | 87.12 | -633,972.24 | -65,8% | |
| 2025-06-10 | Bonstein Sara | Officer, Chief Financial Officer | Open Market Sale | -100 | 91.66 | -9,166.00 | -1,0% | |
| 2025-06-05 | Smith Michael Alexander | Officer, Chief Legal Officer | Open Market Sale | -1,879 | 73.50 | -138,106.50 | -14,3% | |
| 2025-06-03 | Adsett Roger | Officer, Chief Operating Officer | Open Market Sale | -1,860 | 71.50 | -132,990.00 | -13,8% | |
| 2025-06-03 | Smith Michael Alexander | Officer, Chief Legal Officer | Open Market Sale | -1,448 | 71.50 | -103,532.00 | -10,7% | |
| 2025-06-03 | Bonstein Sara | Officer, Chief Financial Officer | Open Market Sale | -1,579 | 71.50 | -112,898.50 | -11,7% | |
| 2025-06-03 | Lewis William | Director, Officer, Chair and CEO | Open Market Sale | -5,472 | 71.50 | -391,248.00 | -40,6% | |
| 2025-06-02 | Lewis William | Director, Officer, Chair and CEO | Open Market Sale | -4,400 | 71.35 | -313,940.00 | -32,6% | |
| 2025-06-02 | Lewis William | Director, Officer, Chair and CEO | Open Market Sale | -1,430 | 71.94 | -102,874.20 | -10,7% | |
| 2025-06-02 | Lewis William | Director, Officer, Chair and CEO | Open Market Sale | -1,000 | 70.23 | -70,230.00 | -7,3% | |
| 2025-05-30 | Smith Michael Alexander | Officer, Chief Legal Officer | Open Market Sale | -20,000 | 70.00 | -1,400,000.00 | -145,3% | |
| 2025-05-30 | Smith Michael Alexander | Officer, Chief Legal Officer | Open Market Sale | -6,327 | 68.56 | -433,779.12 | -45,0% | |
| 2025-05-20 | Lewis William | Director, Officer, Chair and CEO | Open Market Sale | -2,251 | 68.13 | -153,360.63 | -15,9% | |
| 2025-05-20 | Lewis William | Director, Officer, Chair and CEO | Open Market Sale | -9,489 | 66.87 | -634,529.43 | -65,8% | |
| 2025-05-20 | Lewis William | Director, Officer, Chair and CEO | Open Market Sale | -7,088 | 68.49 | -485,457.12 | -50,4% | |
| 2025-05-20 | Lewis William | Director, Officer, Chair and CEO | Open Market Sale | -4,480 | 67.96 | -304,460.80 | -31,6% | |
| 2025-05-20 | Lewis William | Director, Officer, Chair and CEO | Open Market Sale | -2,863 | 66.90 | -191,534.70 | -19,9% | |
| 2025-05-20 | Lewis William | Director, Officer, Chair and CEO | Open Market Sale | -1,716 | 68.54 | -117,614.64 | -12,2% | |
| 2025-05-14 | Smith Michael Alexander | Officer, Chief Legal Officer | Open Market Sale | -409 | 65.61 | -26,834.49 | -2,8% | |
| 2025-05-14 | Adsett Roger | Officer, Chief Operating Officer | Open Market Sale | -1,925 | 65.61 | -126,299.25 | -13,1% |
Fail-to-Deliver (6 Monate)
| Datum | FTD-Menge | Kurs | Wert (USD) |
|---|---|---|---|
| 2026-03-23 | 7 | 136,00 | 952 |
| 2026-03-10 | 206 | 143,13 | 29.485 |
| 2026-03-04 | 10 | 147,00 | 1.470 |
| 2026-03-03 | 67 | 146,32 | 9.803 |
| 2026-02-27 | 41 | 150,00 | 6.150 |
| 2026-02-26 | 2.007 | 148,61 | 298.260 |
| 2026-02-23 | 421 | 164,91 | 69.427 |
| 2026-02-19 | 922 | 151,11 | 139.323 |
| 2026-02-18 | 62 | 150,52 | 9.332 |
Top-Fondshalter
Hinweis: Keine aktuelleren Daten zu dieser Aktie verfuegbar. Stand der gezeigten 13F-Holdings: 31.12.2025. Letztes global veroeffentlichtes 13F-Quartal: 31.03.2026.
| Fonds | Anteile | Wert (USD) | Anteil (%) |
|---|---|---|---|
| JPMORGAN CHASE & CO | 23,556,212 | 4,099,723,379 | 14.31 |
| VANGUARD GROUP INC | 21,076,344 | 3,668,126,910 | 12.81 |
| BlackRock, Inc. | 15,065,052 | 2,621,921,693 | 9.15 |
| FMR LLC | 9,927,936 | 1,727,857,942 | 6.03 |
| BAKER BROS. ADVISORS LP | 6,592,746 | 1,147,401,514 | 4.01 |
| STATE STREET CORP | 5,201,744 | 905,311,526 | 3.16 |
| Capital International Investors | 5,151,671 | 896,597,082 | 3.13 |
| RTW INVESTMENTS, LP | 4,842,879 | 842,854,661 | 2.94 |
| D. E. Shaw & Co., Inc. | 4,364,695 | 759,631,518 | 2.65 |
| GEODE CAPITAL MANAGEMENT, LLC | 4,299,052 | 751,935,864 | 2.63 |
| Orbis Allan Gray Ltd | 4,179,957 | 727,479,716 | 2.54 |
| NORGES BANK | 2,910,971 | 506,625,393 | 1.77 |
| FRANKLIN RESOURCES INC | 2,755,536 | 479,573,482 | 1.67 |
| Invesco Ltd. | 2,726,857 | 474,582,256 | 1.66 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 2,392,776 | 416,438,735 | 1.45 |
| AMERIPRISE FINANCIAL INC | 1,968,857 | 342,660,797 | 1.20 |
| UBS Group AG | 1,950,835 | 339,523,322 | 1.19 |
| CITADEL ADVISORS LLC | 1,808,995 | 314,837,490 | 1.10 |
| BANK OF AMERICA CORP /DE/ | 1,725,681 | 300,337,528 | 1.05 |
| MORGAN STANLEY | 1,631,906 | 284,017,467 | 0.99 |